JRC Publications Repository

JRC Publications Repository >

Browsing by Author APOSTOLIDIS Christos

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 108 to 127 of 140
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2007The Structures and Optical Spectra of Hydrated Transplutonium Ions in the Solid State and in SolutionLINDQVIST-REIS P.; APOSTOLIDIS CHRISTOS; REBIZANT JEAN; MORGENSTERN ALFRED; KLENZE R.; WALTER O.; FANGHAENEL THOMAS; HAIRE R.g.Articles in Journals
1997Structures of the Anhydrous Yb(III) and the Hydrated Ce(III), Sm(III) and Tb(III) Methanesulfonates.ARICO E.m.; ZINNER L.b.; APOSTOLIDIS Christos; DORNBERGER Ernst; REBIZANT JeanArticles in Journals
2000Studies on the Red Marrow Dosimetry in Radioimmunotherapy. An Experimental Investigation of Factors Influencing the Radio-Induced Myelotoxicity in Therapy with beta-, Auger/Conversion Electron-, or alpha-Emitters.BEHR T.m.; SGOUROS G.; STABIN M.g.; BEHE M.; ANGERSTEIN Ch.; BLUMENTHAL R.d.; APOSTOLIDIS Christos; MOLINET Roger; SHARKEY R.m.; KOCH Lothar, et alArticles in Journals
2005Synergistic Antitumor Effects of alpha-Radioimmunotherapy and Paclitaxel or Doxorubicin on Human Myeoloma Cells.SUPIOT S.; FAIVRE-CHAUVET A.; THILLAYS F.; GOUARD S.; APOSTOLIDIS Christos; WIJDENES John; BARBET J.; BATAILLE R.; DAVODEAU F.; CHEREL M.Articles in Journals
2012Synthesis and in vitro evaluation of 225Ac-DOTA-SubstanceP for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA AGNIESZKA; BRUCHERTSEIFER Frank; WEIS Mirjam; BONELLI Milton; LAURENZA M; APOSTOLIDIS Christos; MORGENSTERN AlfredContributions to Conferences
1998Synthesis and Magnetic Properties of (C5H5)3Ce-Center-HMPA.ARICO E.m.; APOSTOLIDIS Christos; ZINNER L.b.Articles in Journals
2013Synthesis of 213Bi-DOTATOC for peptide receptor a-therapy of GEP-NET patients refractory to β-therapyBRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; GIESEL Frederik; MIER Walter; HABERKORN Uwe; KRATOCHWIL ClemensContributions to Conferences
2012Synthesis of 213Bi-DOTATOC for peptide receptor alpha-therapy of GEP-NET patients refractory to beta therapyMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; GIESEL Frederik; MIER Walter; HABERKORN Uwe; KRATOCHWIL ClemensContributions to Conferences
2000Synthesis of a Novel Bifunctional Chelating Agent for Actinium Complexation.QUADI Ali; LOUSSOUARN A.; REMAUD P.; MORANDEAU L.; APOSTOLIDIS Christos; MUSIKAS C.; FAIVRE-CHAUVET A.; GESTIN J.-f.Articles in Journals
2010Synthesis of Bimetallic Uranium and Neptunium Complexes of a Binucleating Macrocycle and Determination of the Solid-State Structure by Magnetic AnalysisARNOLD Polly L.; POTTER Natalie A.; MAGNANI Nicola; APOSTOLIDIS Christos; GRIVEAU Jean-Christophe; COLINEAU Eric; MORGENSTERN Alfred; CACIUFFO Roberto; LOVE Jason B.Articles in Journals
2013Synthesis of transuranium-based nanocrystals via the thermal decomposition of actinyl nitratesHUDRY DAMIEN; APOSTOLIDIS Christos; WALTER OLAF; GOUDER Thomas; JANSSEN ARNE; COURTOIS Eglantine; KUEBEL Christian; MEYER D.Articles in Journals
2013Targeted alpha therapy of glioblastoma multiforme with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOCIARA Henryk; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2013Targeted alpha therapy of glioblastoma multiforme: initial clinical experience with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2005Targeted Alpha Therapy with 213 Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer.QU Chang f.; SONG Yang j.; LI Yong; RIZVI S.m.a.; RAJA Chand; SMITH R.; MORGENSTERN A.; APOSTOLIDIS Christos; ALLEN B.j.Articles in Journals
2011Targeted alpha therapy with 213BiMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
2010Targeted Alpha-Radionuclide Therapy of Functionally Critical Located Gliomas with 213Bismuth-DOTA-[Thi8,Met(O2)11]-Substance P - A Pilot TrialCORDIER D.; FORRER F.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; GOOD S.; MÜLLER-BRAND J.; MÄCKE H.; REUBI Jean-Claude; MERLO A.Articles in Journals
2006Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral ProteinsDADACHOVA E.; PATEL Martil; TOUSSI S.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; BRECHBIEL M.; GORNY M.k.; ZOLLA-PAZNER S.; CASADEVALL A.; GOLDSTEIN H.Articles in Journals
2014Thorium / Uranium Mixed Oxide Nanocrystals: Synthesis, Structural Characterization and Magnetic PropertiesHUDRY DAMIEN; GRIVEAU Jean-Christophe; APOSTOLIDIS Christos; WALTER OLAF; COLINEAU Eric; RASMUSSEN Gert; WANG Di; CHAKRAVADHALUNA Kiran; COURTOIS Eglantine; KUEBEL Christian, et alArticles in Journals
1996Tris(mu5-cyclopentadienyl)phenolatoneptunium(IV).DE RIDDER Dirk; APOSTOLIDIS Christos; REBIZANT Jean; MAIER RalphArticles in Journals
2000Tumor Binding and Therapeutic Efficacy of 213-Bi Labeled Mutation Specific Monoclonal Antobody in a Human Intraperitoneal Gastric Cancer Model.SENEKOWITSCH-SCHMIDTKE R.; FISCHER K.; SCHUMACHER C.; BECKER I.; BECKER K.; APOSTOLIDIS Christos; NIKULA T.; SCHWAIGER M.Contributions to Conferences
Showing results 108 to 127 of 140

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top